FSGS (Focal Segmental Glomerulosclerosis)
Mohamed A. El-Shahawy, MD, MPH, MHA, FASN, CPI
Director and Principal Investigator
Clinical Professor of Medicine (Adjunct), Keck School of Medicine of USC
Protocol Overview
This Protocol will evaluate the efficacy of an investigational medication, in addition to evidence-based standard of care therapy aiming to reduce proteinuria and delaying the progression of kidney disease.
Key Inclusions Criteria
- Adults aged 18 to 75 years
- Urine Protein Excretion- UPCR ≥ 0.75 g/g
- Kidney Function (eGFR): ≥ 30 mL/min/1.73 m²
Why Join This Clinical Trial?
– Access to highly experienced Board certified Nephrologists
– Participation is voluntary, and you will learn all details about the protocol by Contacting with our clinical team contact us.
– Clinical trials offer additional care options for your condition, with access to new medicines at no cost.
– Help move science forward and improve human health, wellbeing, and quality of life.
– No cost to participate.
Compensation
- $75.00 per each completed visit
- If you complete all protocol visits, the total compensation would be $1,650.
- Free Transportation will be provided.
Connect with Our Clinical Team
